Guardian Pharmacy Services, INC Form 4 insider transactions

William Franklin Mudd, See Remarks of Guardian Pharmacy Services, Inc., reported multiple transactions in common stock on September 27, 2026.

Robert Weir, See Remarks of Guardian Pharmacy Services, Inc., reported multiple transactions in common stock on September 27, 2026.

John Ackerman, a Director of Guardian Pharmacy Services, Inc., reported multiple transactions in common stock on September 27, 2026.

Thomas J Salentine Jr, a Director and 10% owner of Guardian Pharmacy Services, Inc., reported multiple transactions in common stock on September 27, 2026.

David Norman Martin, See Remarks of Guardian Pharmacy Services, Inc., reported multiple transactions in common stock on September 27, 2026.

Pharmacy Investors, LLC reported changes in beneficial ownership of Guardian Pharmacy Services, Inc. common stock on September 27, 2026.

Fred Burke, See Remarks and a Director of Guardian Pharmacy Services, Inc., reported multiple transactions in common stock on September 27, 2026.

Jeffrey Tuch, See Remarks of Guardian Pharmacy Services, Inc., reported multiple transactions in common stock on September 27, 2026.

Kendall Forbes, Member of 10% Owner Group of Guardian Pharmacy Services, Inc., reported multiple transactions in common stock on September 27, 2026.

William E Bindley, a Director and 10% owner of Guardian Pharmacy Services, Inc., reported multiple transactions in common stock on September 27, 2026.

David K Morris, See Remarks and a Director of Guardian Pharmacy Services, Inc., reported multiple transactions in common stock on September 27, 2026.

Chris Crisafulli, See Remarks of Guardian Pharmacy Services, Inc., reported multiple transactions in common stock on September 27, 2026.

Richard Eakins, Senior Vice President, Sales of Guardian Pharmacy Services, Inc., reported multiple transactions in common stock on September 27, 2026.

Cardinal Equity Fund, L.P. reported changes in beneficial ownership of Guardian Pharmacy Services, Inc. common stock on September 27, 2026.

Bindley Capital Partners I, LLC reported changes in beneficial ownership of Guardian Pharmacy Services, Inc. common stock on September 27, 2026.

Douglas Towns, See Remarks of Guardian Pharmacy Services, Inc., reported multiple transactions in common stock on September 27, 2026.

Mary Sue Patchett, a Director at Guardian Pharmacy Services, Inc., reported the acquisition of 4,028 shares of Class A Common Stock on May 5, 2026.

Pharmacy Investors, LLC, a member of a 10% owner group, converted 1,413,939 shares of Guardian Pharmacy Services, Inc. Class B common stock to Class A common stock.

William E. Bindley, a Director and 10% Owner of Guardian Pharmacy Services, Inc., converted over 6 million Class B common shares into Class A common shares as part of a pre-scheduled event.

Kendall Forbes, EVP of Guardian Pharmacy Services, converted 608,570 Class B common shares to Class A common shares as part of a scheduled plan.

David K. Morris, CFO of Guardian Pharmacy Services, Inc., converted 641,869 shares of Class B common stock into Class A common stock as part of a pre-scheduled automatic conversion.

Cardinal Equity Fund, L.P. converted 471,057 Class B common shares of Guardian Pharmacy Services, Inc. into Class A common shares as part of a pre-scheduled automatic conversion.

Bindley Capital Partners I, LLC converted 6,100,175 shares of Guardian Pharmacy Services, Inc. Class B common stock into Class A common stock.

A director and 10% owner of Guardian Pharmacy Services converted Class B common stock into Class A common stock, increasing their beneficial ownership of Class A shares.

A director and 10% owner of Guardian Pharmacy Services, Inc. reported the automatic conversion of over 6.1 million Class B common shares into Class A common shares.

Guardian Pharmacy Services CEO Fred Burke converted over 1.2 million Class B common shares to Class A common shares as part of a pre-scheduled automatic conversion.

Pharmacy Investors, LLC reported the sale of 827,636 shares of Guardian Pharmacy Services, Inc. Class A Common Stock for $29.6825 per share.

Guardian Pharmacy Services' CFO, David K. Morris, sold 187,855 shares of Class A common stock for approximately $5.58 million under a pre-arranged plan.

Fred Burke, President and CEO of Guardian Pharmacy Services, Inc., sold 671,432 shares of Class A Common Stock for approximately $19.9 million.

Kendall Forbes, Executive Vice President of Guardian Pharmacy Services, sold 346,672 shares of Class A Common Stock for approximately $10.3 million.